Ranlu Liu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Prostate Cancer

Histone Deacetylase

Induced Apoptosis

Top Venues

Molecular cancer research : MCR

Combinatorial chemistry & high throughput screening

This page only lists publications with an associated author ORCID identifier.

Publications

Xing-Kang Jiang, Yong Xu, Ranlu Liu, Shan-Qi Guo
Exosomal lincROR promotes docetaxel resistance in prostate cancer through a β-catenin/HIF-1α positive feedback loop. Molecular cancer research : MCR (2023)
Shangrong Wu, Xudong Ma, Zhengxin Liang, Yuchen Jiang, Shuaiqi Chen, Guangyu Sun, Kaifei Chen, Ranlu Liu
Development and validation of a nomogram for predicting osteoporosis in prostate cancer patients: A cross-sectional study from China. The Prostate (2023)
Xudong Ma, Xifeng Wei, Guanghua Yang, Shuai Li, Ranlu Liu
A novel Natural killer cell-related gene signature for improving the prediction of prognosis and immunotherapy response in bladder cancer. Combinatorial chemistry & high throughput screening (2023)
Taihao Chang, Zhenpeng Lian, Shenfei Ma, Zhengxin Liang, Xudong Ma, Xiaodong Wen, Yanming Wang, Ranlu Liu
Combination with vorinostat enhances the antitumor activity of cisplatin in castration-resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH. The Prostate 83 (5) (2022)
Taihao Chang, Zhenpeng Lian, Shenfei Ma, Zhengxin Liang, Xudong Ma, Xiaodong Wen, Yanming Wang, Ranlu Liu
Combination with vorinostat enhances the antitumor activity of cisplatin in castration-resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH. The Prostate (2022)
Taihao Chang, Zhenpeng Lian, Shenfei Ma, Zhengxin Liang, Xudong Ma, Xiaodong Wen, Yanming Wang, Ranlu Liu
Combination with vorinostat enhances the antitumor activity of cisplatin in castration-resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH. The Prostate 83 (5) (2022)